Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.095 USD | -0.71% | -12.30% | +21.59% |
03-14 | Top Premarket Gainers | MT |
03-13 | Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Newman
FOU | Founder | 68 | 21-02-23 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 21-08-02 |
Nir Sassi
DFI | Director of Finance/CFO | 48 | 21-06-30 |
Roger Waltzman
CTO | Chief Tech/Sci/R&D Officer | 56 | 23-08-06 |
Walt Linscott
COO | Chief Operating Officer | 63 | 21-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Hayes
BRD | Director/Board Member | 58 | 21-08-02 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 21-08-02 |
Director/Board Member | 61 | 23-01-12 | |
Hila Karah
BRD | Director/Board Member | 55 | 21-06-30 |
Michael Newman
FOU | Founder | 68 | 21-02-23 |
Roger Pomerantz
CHM | Chairman | 67 | 21-07-31 |
Director/Board Member | 71 | 21-06-30 | |
Mark Gilbert
BRD | Director/Board Member | 63 | 21-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,538,883 | 5,902,783 ( 69.13 %) | 0 | 69.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.59% | 18.02M | |
+1.46% | 42.75B | |
+47.70% | 41.61B | |
+11.69% | 41.34B | |
-8.83% | 26.59B | |
+6.45% | 25.49B | |
-23.58% | 18.12B | |
+29.87% | 12.24B | |
-2.41% | 11.76B | |
+7.93% | 11B |
- Stock Market
- Equities
- INDP Stock
- Company Indaptus Therapeutics, Inc.